McKinsey July 28, 2025
Paul Hudson, Hemant Ahlawat, and Lareina Yee

The global biopharmaceutical company is using AI and agentic AI to accelerate how it chases breakthroughs in medicine.

Paul Hudson, CEO of Sanofi, has been driving an all-encompassing effort to use AI to reshape the way the company does business. He’s a vocal advocate for the technology and its great potential. Working with external AI partners, he’s pushing Sanofi to become the AI leader in its industry. What follows is an edited version of his conversation with McKinsey Senior Partners Hemant Ahlawat and Lareina Yee.

Lareina Yee: Paul, there has been a lot of change in the world since you became CEO of Sanofi in 2019. In technology, we have...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article